01 — What is it?
A mitochondria-derived peptide studied for metabolic signaling, stress responses and exercise-related biology. Human evidence remains limited compared with established metabolic drugs.
Database / Research Profiles / MOTS-C
RESEARCH PROFILE
MOTS-C
Mitochondrial-derived peptide • 16 amino acids
MitochondrialLimited human evidence
EVIDENCE SNAPSHOTLIMITED HUMAN EVIDENCE
Mostly preclinical plus limited human observational/exercise research; no validated clinical dosing protocol.
Research-first: This profile summarizes published evidence and regulatory context. It is educational reference material, not a diagnosis, treatment recommendation, or personalized dosing protocol.
02 — Research category
Mitochondrial. Evidence strength is based on the availability and quality of human clinical data, not on popularity in the research-peptide market.
03 — Evidence map
Human evidence: YESPreclinical evidence: YESPersonal dosing protocol: NOT PROVIDED
Mostly preclinical plus limited human observational/exercise research; no validated clinical dosing protocol.
04 — Mechanism / biology
A mitochondria-derived peptide studied for metabolic signaling, stress responses and exercise-related biology. Human evidence remains limited compared with established metabolic drugs.
05 — Safety & limitations
Safety depends on the exact molecule, formulation, route, dose, indication and study population. Research-market products may differ in identity, purity, sterility or stability from materials used in published trials. Absence of reported adverse events in a small study does not establish long-term safety.
06 — Regulatory context
Regulatory status varies by compound and jurisdiction. Where an approved product exists, its approval applies only to specified formulations and indications. Investigational or research-market status should not be presented as equivalent to approval.